NCT03445078

Brief Summary

Previous literature has found potential association between selenium deficiency and inactivated glutathione peroxidase and deiodinase, which may contribute to subsequent elevation of T4 and ratio of T4/T3. Conduction of a case-control study (ID: Liuyanping3) has been applied on Clinicaltrials.gov to further elucidate effect of selenium deficiency on thyroid function. Based on its data, the investigators will perform a randomized, placebo-controlled,single-blinded crossover study on 20 participants with selenium deficiency to verify health consequence of selenium.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2018

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 7, 2018

Completed
19 days until next milestone

First Posted

Study publicly available on registry

February 26, 2018

Completed
6 months until next milestone

Study Start

First participant enrolled

September 1, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

May 31, 2018

Status Verified

May 1, 2018

Enrollment Period

3 months

First QC Date

February 7, 2018

Last Update Submit

May 29, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • comparison of thyroid function

    comparison of thyroid function between administration of selenium supplementation and placebo

    plasma sample will be collected at -1w/4w/8w/12w

Secondary Outcomes (3)

  • comparison of serum selenium

    plasma sample will be collected at -1w/4w/8w/12w

  • comparison of erythrocyte glutathione peroxidase activity

    plasma sample will be collected at -1w/4w/8w/12w

  • comparison of serum deiodinase activity

    plasma sample will be collected at -1w/4w/8w/12w

Study Arms (2)

A

ACTIVE COMPARATOR

Participants will be administered firstly selenium-rich corn powder 20g/d for 1 month and ordinary corn powder 20g/d for another month subsequently with a month washout period.

Dietary Supplement: selenium supplementationDietary Supplement: ordinary corn powder

B

PLACEBO COMPARATOR

Participants will be administered firstly ordinary corn powder 20g/d for 1 month and selenium-rich corn powder 20g/d for another month subsequently with a month washout period.

Dietary Supplement: selenium supplementationDietary Supplement: ordinary corn powder

Interventions

selenium supplementationDIETARY_SUPPLEMENT

administration of selenium-rich corn powder 20g/d offering selenium 100μg/d

AB
ordinary corn powderDIETARY_SUPPLEMENT

ordinary corn powder,20g/d(selenium contain \<0.5ug/20g).

Also known as: low selenium
AB

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of selenium deficiency through serum selenium test in previous phase (ID: Liuyanping3) of the study
  • Should have stable body weight in the latest 3 months;
  • Should be not prescribed with thyroid hormone replacement therapy
  • Should be without medical history of thyroid surgery or iodine radiotherapy
  • Should have normal FT3, FT4 and TSH.

You may not qualify if:

  • Clinical diagnosis of acute critical illness in the latest 1 year
  • Have had weight fluctuation by more than 5%
  • Eating disorders
  • Neuropsychological disorders
  • Allergy to corn or yeast

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
All participants will be blinded. Both the selenium-rich corn powder and the ordinary corn powder (placebo) have the same smell, color and taste.
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: 20 participants with selenium deficiency (confirmed in previous phase (ID: Liuyanping3)) will be recruited to receive selenium-rich corn powder (20g/d, offering selenium 100μg/d) and ordinary corn powder (20g/d, offering selenium \< 0.5μg/d ) in two different sequences (10 subjects each) with a four-week washout period.Plasma samples were obtained at different time points before and after administration of the selenium-rich corn powder and ordinary corn powder.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
nutrition physician

Study Record Dates

First Submitted

February 7, 2018

First Posted

February 26, 2018

Study Start

September 1, 2018

Primary Completion

December 1, 2018

Study Completion

April 1, 2019

Last Updated

May 31, 2018

Record last verified: 2018-05